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Intravascular large B-cell lymphoma (IVLBCL) is a rare malignant neoplasm classified as a distinct clini-copathological subtype of extranodal diffuse large 
B-cell lymphoma according to the WHO classification.1 
IVLBCL usually occur in adults, is usually widely dis-
seminated at presentation and may involve virtually any 
organ. Clinical signs and symptoms at presentation are 
non-specific and are usually related to the main organ 
involved. Neurological and cutaneous manifestations are 
common in early stages, but the patient may present in 
the late stages with pancytopenia, hepatosplenomegaly 
and multiorgan failure. Diagnosis is made when the tis-
sue biopsy shows the selective presence of neoplastic 
lymphoid cells in the lumina of vessels in various organs 
and is confirmed when these tumor cells express B-cell-
associated antigens.2 IVLBCL is often diagnosed late or 
at postmortem because of the non-specific clinical pre-
sentation, difficulty in histological diagnosis and aggres-
sive clinical behavior. Even when diagnosed earlier, the 
response to chemotherapy is often poor.3 In this report, 
we describe a case of IVLBCL diagnosed on bone tre-
phine biopsy with a fulminant clinical course and a fatal 
outcome. 
CAsE
A 86-year-old male presented with a history of fever, 
weight loss, shortness of breath and altered mental sta-
tus. Examination revealed pallor and splenomegaly. At 
presentation, results of complete blood counts showed 
bicytopenia with a hemoglobin of 10.7 gm/dL (normal 
reference range, 13.7-16.3 g/dL), hematocrit 32% (nor-
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intravascular large b-cell lymphoma (iVlbcl) is a rare subtype of extranodal large b-cell lymphoma char-
acterized by a selective proliferation of lymphoma cells within the lumina of vessels. We report a case of 
an 86-year-old man who presented with fever, shortness of breath and altered mental status. the diagnosis 
of iVlbcl was confirmed on a bone trephine biopsy that revealed positivity of cd20 and paX5 immuno-
histochemical staining of lymphoma cells confined within the lumina of vessels. the patient had a rapidly 
deteriorating clinical course with a fatal outcome even before the specific treatment for the underlying 
disease was commenced.
mal reference range, 41.9%-48.7%), mean corpuscular 
volume of 89.7 fL (normal reference range, 76.0-96.0 fL), 
mean corpuscular hemoglobin of 30 pg (normal refer-
ence range, 26.0-32.0 pg/cell), a total white cell count of 
5.1×109/L (normal reference range, 4.0-10.0×109/L), an 
absolute neutrophil count of 2.2×109/L and platelets of 
19×109/L (normal reference range, 150-400×109/L). A 
peripheral blood film revealed normochromic anemia and 
thrombocytopenia, with no leukemic blasts or circulating 
lymphoma cells. Other relevant laboratory tests showed 
elevated LDH (2864 U/L normal reference range, 253-
548 U/L) and uric acid (10.1 mg/dL normal reference 
range, 4.1-8.0 mg/dL). Abdominal ultrasound showed 
splenomegaly (18 cm); however, there was no evidence of 
cervical, thoracic or abdominal lymphadenopathy on CT 
scan. The patient was hospitalized for management, but 
his condition deteriorated rapidly with worsening cyto-
penia and progressive respiratory failure. He was moved 
to the intensive care unit and required ventilation support 
on day 3 of admission. He required frequent transfusions 
with packed red cells and platelet concentrates along with 
broad-spectrum antibiotics and other supportive care. In 
view of the cytopenia, splenomegaly and elevated LDH, a 
bone trephine biopsy was preformed, which showed pro-
liferation of large atypical lymphoid cells with a moderate 
amount of cytoplasm, vesicular nuclei and prominent nu-
cleoli within the vascular and sinusoidal structure of the 
bone trephine biopsy (Figure 1). Immunohistochemical 
staining of atypical lymphoid cells showed strong posi-
tivity for B-cell marker CD20 and PAX5 (Figures 2, 3). 
Vascular lining was highlighted by positivity for CD34. 
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CD5 was also positive in lymphoma cells while other 
markers like CD3, CD43, CD10, CD30 and cyclin-D1 
were negative, confirming the morphological and immu-
nohistochemical diagnosis of the intravascular subtype of 
large B-cell lymphoma. In the following days, his condi-
tion further deteriorated despite continued supportive 
care leading to a fatal outcome secondary to progressive 
cardiorespiratory insufficiency and multiorgan failure. 
The patient died on day 7 of admission. 
DIsCussIOn
IVLBCL, also known as angiotropic large cell lymphoma, 
is a rare and pathologically distinct sub-type of non-
Hodgkin lymphoma characterized by varied clinical spec-
trum and distinct immunophenotypic profile. Afflicted 
patients are usually middle-aged or elderly with a median 
age of 67 years at presentation (range, 41-85 years).2 The 
altered mental status of the patient in our report is more 
likely related to CNS involvement, which is observed in 
two-thirds of cases with IVLBCL4 and is attributed to 
multiple infarcts secondary to vascular occlusion.5 Most 
cases of IVLBCL present with bicytopenia, most com-
monly anemia and thrombocytopenia, along with hepato-
splenomegaly;2 both features were present in this case. 
Virtually any organ can be involved in IVLBCL, but 
bone marrow is usually spared. Bone marrow findings 
are usually described as unremarkable and involvement 
with neoplastic lymphoma cells are noted in rare cases.6 
Histopathological findings in IVLBCL show a charac-
teristic proliferation of lymphoma cells within the lumina 
of vessels exhibiting typical positivity for pan-B immu-
nohistochemical stains, e.g. CD 20 and CD79. Although 
the case described here showed typical positivity of lym-
phoma cells for CD20, the more recent B-cell immuno-
histochemical stain PAX5 positivity is reported for the 
first time in IVLBCL to the best of our knowledge. The 
IVLBCL case reported here also showed distinct immu-
nophenotypic profile of CD5+ and CD10−, the pattern 
related to poor prognosis.2 
IVLBCL usually shows rapid progression and short 
survival.7 The poor prognosis in these patients reflects 
the non-specific signs and symptoms and late stage at 
presentation, the widely disseminated nature of the dis-
ease, the delay in diagnosis, and the delay in initiation of 
therapy. The patient described here unfortunately had a 
highly aggressive disease and succumbed to cardiorespi-
ratory insufficiency and multiorgan failure even before 
the specific therapy could be initiated. Such cases have 
been reported as ‘catastrophic’ cases of IVLBCL mani-
festing as adrenal insufficiency, thrombotic microangi-
opathy, progressive dementia, and interstitial pneumonia 
or multiorgan failure.3
Figure 1. bone trephine biopsy section. intravascular large b-
cell lymphoma, showing sinusoids packed with large atypical 
lymphoid cells. Hematoxylin and eosin ×200.
Figure 2. bone trephine biopsy section. lymphoma cells within 
the vessels highlighted by CD20. immunohistochemical stain with 
anti-CD20 ×200.
Figure 3. intravascular large b-cell lymphoma. Tumor cells 
showing nuclear expression of PaX5. immunohistochemical 
stain with PaX5 antibody ×400.
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